← Evidence map

ArticleCritical care (London, England)2022

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT.

Patrick M Honore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34996512